Progress Adult Study

NCT ID: NCT01328275

Last Updated: 2016-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-12-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

long-term follow-up of HIV-infected patients on ART

standard regimens according to the Thai Ministry of Public Health national guidelines

Intervention Type DRUG

Participants may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

standard regimens according to the Thai Ministry of Public Health national guidelines

Participants may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens
2. Signed consent form
3. Age\> 18 years

Exclusion Criteria

1. Patients who came for treatment in a department other than out patient, such as inpatient or emergency room.
2. Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of.
3. Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data.
4. Patients who have been diagnosed by a medical condition that Alcoholism
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bamrasnaradura Infectious Diseases Institute

OTHER_GOV

Sponsor Role collaborator

Sanpatong Hospital

UNKNOWN

Sponsor Role collaborator

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wisit Prasithsirikul, MD

Role: PRINCIPAL_INVESTIGATOR

Bamrasnaradura infectious disease institute

Wirat Klinbuayam, MD

Role: PRINCIPAL_INVESTIGATOR

Sanpatong Hospital

Jintanat Ananworanich, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

HIV-NAT, Thai Red Cross - AIDS Research Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bamrasnaradura infectious disease institute

Nonthaburi, Changwat Nonthaburi, Thailand

Site Status

Sanpatong Hospital

Chiang Mai, Chiang Mai, Thailand

Site Status

HIV-NAT, Thai Red Cross AIDS Research Centre

Bangkok, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

References

Explore related publications, articles, or registry entries linked to this study.

Pongpirul W, Pongpirul K, Ananworanich J, Klinbuayaem V, Avihingsanon A, Prasithsirikul W. Chronic kidney disease incidence and survival of Thai HIV-infected patients. AIDS. 2018 Jan 28;32(3):393-398. doi: 10.1097/QAD.0000000000001698.

Reference Type DERIVED
PMID: 29135575 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.hivnat.org

HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HIV-NAT 153

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Pharmacology/Aging Clinic
NCT01286623 COMPLETED